Walgreens Listed as Defendant
In Michigan, 70 plaintiffs have filed suit against companies that failed to warn them of risk of tardive dyskinesia, the neurological movement disorder side effect of Reglan.
In addition to the drug makers, Walgreens, the national drug store chain, is listed as a defendant.The plaintiffs say Walgreens should have provided notifications once their medication regimen exceeded 12 weeks, the maximum length of time one should be on Reglan.
Patients who take Reglan long-term (12 weeks or more) are at higher risk for developing tardive dyskinesia, a neurological disorder that causes involuntary movements, like tongue thrusting, grimacing, and rapid blinking. There is no cure for tardive dyskinesia, and medications to help control the movements can be expensive.